Highbridge Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
Similar funds
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.